Analysts expect that Mead Johnson Nutrition will post $3.37 EPS for the current fiscal year. Other equities research analysts have also recently issued reports about the stock. Analysts at Jefferson Research downgraded shares of Mead Johnson Nutrition from a buy rating to a hold rating in a research note to investors on Tuesday, October 29th. Separately, analysts at Citigroup Inc. upgraded shares of Mead Johnson Nutrition from a neutral rating to a buy rating in a research note to investors on Monday, October 21st. They now have a $95.00 price target on the stock, up previously from $77.00.
For the original version including any supplementary images or video, visit http://www.wkrb13.com/markets/223698/mead-johnson-nutrition-price-target-raised-to-89-00-at-jpmorgan-chase-co-mjn/
Medical Nutrition – A Global Market Overview
” Medical Nutrition – A Global Market Overview” reviews and analyses the worldwide market for medical nutrition products for the global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 15 independent countries across North America – the United States, Canada and Mexico; Europe – Germany, France, the United Kingdom, Italy, Spain and Rest of Europe; Asia-Pacific – Japan, China, India, South Korea and Rest of Asia-Pacific; South America – Brazil, Argentina and Rest of South America. This 387 page global market report includes 180 rich data tables, supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value by geographic regions, product segments/sub-segments. This market report covers the brief business profiles of 25 key global players and 46 major players across North America – 28; Europe – 12; and Asia-Pacific – 6.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/medical-nutrition-global-market-overview-191500430.html